Business
PRTC Appoints Merck Vet to BOD & Audit Committee
PRTC Appoints Merck Vet to BOD & Audit Committee.
About this update from Puretech Health Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 8327F\n PureTech Health PLC\n 24 March 2022\n \n \n \n \n 24 March 2022\n \n \n PureTech Health plc\n \n \n \n \n \n PureTech Appoints Sharon Barber-Lui to Board of Directors & Audit Committee\n \n \n \n \n \n Seasoned life sciences expert brings further global portfolio management and financial expertise from 20 years at Merck & Co. Inc. to the PureTech board\n \n \n \n \n \n Ms. Barber-Lui will also become chair of the Audit Committee of the board \n \n \n \n \n \n \n \n PureTech Health plc\n \n \n (Nasdaq: PRTC, LSE: PRTC) (\"PureTech\" or the \"Company\"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced the appointment of Sharon Barber-Lui, MBA, CPA, to its board of directors as a non-executive director and as a member of the Audit Committee. She previously led U.S. Oncology Portfolio Market Strategy, Operations and Business Analytics at Merck & Co. Inc. During her two decades at Merck & Co. Inc., Ms. Barber-Lui has held multiple financial and operational positions of increasing responsibility, including Chief Financial Officer of U.S. Oncology, Director of U.S. Treasury Operations and regional Treasurer of Asia Pacific. She currently serves as the Senior Vice President of Global Finance at EQRx. Ms. Barber-Lui brings extensive experience in finance, operations, portfolio management and commercialization to PureTech's board of industry, business and academic leaders. \n \n \n \n \n \n \"Sharon has a track record of success and leadership spanning diverse experiences across the life sciences industry, with particular expertise in financial systems and governance. We are very pleased to have her join PureTech's board,\" said Christopher Viehbacher, Chair of PureTech's Board of Directors. \"On behalf of the board, I welcome Sharon and look forward to her contributions.\"\n \n \n \n \n \n \"I am energized by PureTech's unique model and approach to creating new therapies for devastating diseases,\" commented Ms. Barber-Lui. \"PureTech is a true pioneer, and I look forward to joining the distinguished members of the board to help support PureTech's talented team in executing on the collective vision of transforming patient care...